Gorenoi V, Hagen A (May 2014). "[Percutaneous coronary intervention in addition to optimal medical therapy for stabile coronary artery disease - a systematic review and meta-analysis]". Deutsche Medizinische Wochenschrift. 139 (20): 1039–45. doi:10.1055/s-0034-1369879. PMID24801298. S2CID256699436.
Jang JS, Jin HY, Seo JS, et al. (August 2012). "The transradial versus the transfemoral approach for primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis". EuroIntervention. 8 (4): 501–10. doi:10.4244/EIJV8I4A78. PMID22581470.
Claessen BE, Henriques JP, Dangas GD (2010). "Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems". Curr Pharm Des. 16 (36): 4012–24. doi:10.2174/138161210794454941. PMID21208185.
Mieres J, Fernandez-Pereira C, Risau G, et al. (2012). "One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)". Cardiovasc Revasc Med. 13 (5): 265–271. doi:10.1016/j.carrev.2012.06.001. PMID22796496.
Doenst T, Haverich A, Serruys P, Bonow RO, Kappetein P, Falk V, Velazquez E, Diegeler A, Sigusch H (March 2019). "PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week". J Am Coll Cardiol. 73 (8): 964–976. doi:10.1016/j.jacc.2018.11.053. PMID30819365. S2CID73467926.
Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ (2015). "Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective". Heart. 101 (24): 1980–8. doi:10.1136/heartjnl-2015-307578. hdl:1765/80224. PMID26552756. S2CID37086776.
Bernard R Chaitman, Maria Mori Brooks, Kim Fox, Thomas F Lüscher. ORBITA revisited: what it really means and what it does not? European Heart Journal, Volume 39, Issue 11, 14 March 2018, Pages 963–965, https://doi.org/10.1093/eurheartj/ehx796
Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ (2015). "Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective". Heart. 101 (24): 1980–8. doi:10.1136/heartjnl-2015-307578. hdl:1765/80224. PMID26552756. S2CID37086776.
Gorenoi V, Hagen A (May 2014). "[Percutaneous coronary intervention in addition to optimal medical therapy for stabile coronary artery disease - a systematic review and meta-analysis]". Deutsche Medizinische Wochenschrift. 139 (20): 1039–45. doi:10.1055/s-0034-1369879. PMID24801298. S2CID256699436.
Jang JS, Jin HY, Seo JS, et al. (August 2012). "The transradial versus the transfemoral approach for primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis". EuroIntervention. 8 (4): 501–10. doi:10.4244/EIJV8I4A78. PMID22581470.
Movahed MR, Hashemzadeh M, Jamal MM, Ramaraj R (2010). "Decreasing in-hospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the United States". J Invasive Cardiol. 22 (2): 58–60. PMID20124588.
Claessen BE, Henriques JP, Dangas GD (2010). "Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems". Curr Pharm Des. 16 (36): 4012–24. doi:10.2174/138161210794454941. PMID21208185.
Mieres J, Fernandez-Pereira C, Risau G, et al. (2012). "One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)". Cardiovasc Revasc Med. 13 (5): 265–271. doi:10.1016/j.carrev.2012.06.001. PMID22796496.
Doenst T, Haverich A, Serruys P, Bonow RO, Kappetein P, Falk V, Velazquez E, Diegeler A, Sigusch H (March 2019). "PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week". J Am Coll Cardiol. 73 (8): 964–976. doi:10.1016/j.jacc.2018.11.053. PMID30819365. S2CID73467926.
Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ (2015). "Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective". Heart. 101 (24): 1980–8. doi:10.1136/heartjnl-2015-307578. hdl:1765/80224. PMID26552756. S2CID37086776.
Gorenoi V, Hagen A (May 2014). "[Percutaneous coronary intervention in addition to optimal medical therapy for stabile coronary artery disease - a systematic review and meta-analysis]". Deutsche Medizinische Wochenschrift. 139 (20): 1039–45. doi:10.1055/s-0034-1369879. PMID24801298. S2CID256699436.
Doenst T, Haverich A, Serruys P, Bonow RO, Kappetein P, Falk V, Velazquez E, Diegeler A, Sigusch H (March 2019). "PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week". J Am Coll Cardiol. 73 (8): 964–976. doi:10.1016/j.jacc.2018.11.053. PMID30819365. S2CID73467926.
Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ (2015). "Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective". Heart. 101 (24): 1980–8. doi:10.1136/heartjnl-2015-307578. hdl:1765/80224. PMID26552756. S2CID37086776.